Weight management in perimenopause with hypothyroidism

Thanks for asking—here’s the clean take. The key is to stack the proven basics first, then add meds if needed. With hypothyroidism and perimenopause, weight loss is harder but absolutely doable and still the main lever for lowering heart risk. - First steps: make sure TSH is well-controlled, aim for 7–8 hours sleep, and track waist (goal waist-to-height ≤0.5). Use an India-adapted Mediterranean pattern (more dal/beans, soy/paneer, eggs/fish if you eat them; plenty of veg; swap refined carbs for millets/whole atta; cut sugary/ultra-processed snacks). Target protein ~1.2 g/kg/day, calories modestly reduced, and 150+ min/week activity plus 2–3 strength sessions. - GLP-1s: effective for weight and glucose, reduce cardiovascular events in type 2 diabetes, and can be appropriate if lifestyle alone isn’t enough or BMI is high/complicated by prediabetes. Common issues: nausea, cost, supply; avoid if personal/family history of medullary thyroid cancer or MEN2. - HRT: use for bothersome vasomotor symptoms or sleep/mood disruption, not as a primary weight-loss tool. When started within 10 years of menopause and without contraindications, cardiovascular risk is generally neutral/possibly favorable; it can slightly reduce central fat but won’t substitute for diet/exercise. Requires uterus-safe regimen (estrogen + progesterone) and breast/cancer/VTE screening. Current best approach is: optimize thyroid, lock in lifestyle for 8–12 weeks with objective tracking, then add a GLP-1 if weight or glycemia aren’t moving enough; use HRT for symptom relief if you’re a good candidate. We advocate this because it addresses root risk (adiposity/insulin resistance) while keeping benefits and safety in balance.